Amlexanox Reversibly Inhibits Cell Migration and Proliferation and Induces the Src-dependent Disassembly of Actin Stress Fibers in Vitro *

Amlexanox binds S100A13 and inhibits the release of fibroblast growth factor 1 (FGF1). Because members of the S100 gene family are known to be involved with the function of the cytoskeleton, we examined the ability of amlexanox to modify the cytoskeleton and report that amlexanox induces a dramatic reduction in the presence of actin stress fibers and the appearance of a random, non-oriented distribution of focal adhesion sites. Correspondingly, amlexanox induces the complete and reversible non-apoptotic inhibition of cell migration and proliferation, and although amlexanox does not induce either the down-regulation of F-actin levels or the depolymerization of actin filaments, it does induce the tyrosine phosphorylation of cortactin, a Src substrate known to regulate actin bundling. In addition, a dominant negative form of Src is able to partially rescue cells from the effect of amlexanox on both the actin cytoskeleton and cell migration. In contrast, the inhibition of cell proliferation by amlexanox correlates with the inhibition of cyclin D1 expression without interference of the receptor tyrosine kinase/mitogen-activated protein kinase signaling pathway. Last, the ability of amlexanox to inhibit FGF1 release is reversible and correlates with the restoration of the actin cytoskeleton, suggesting a role for the actin cytoskeleton in the FGF1 release pathway.

[1]  L. Cramer Role of actin-filament disassembly in lamellipodium protrusion in motile cells revealed using the drug jasplakinolide , 1999, Current Biology.

[2]  J. Parsons,et al.  Complex formation with focal adhesion kinase: A mechanism to regulate activity and subcellular localization of Src kinases. , 1999, Molecular biology of the cell.

[3]  Michael P. Sheetz,et al.  Selective regulation of integrin–cytoskeleton interactions by the tyrosine kinase Src , 1999, Nature Cell Biology.

[4]  K. Kohama,et al.  Regulation of Actin Binding and Actin Bundling Activities of Fascin by Caldesmon Coupled with Tropomyosin* , 1998, The Journal of Biological Chemistry.

[5]  Thomas Maciag,et al.  The Extravesicular Domain of Synaptotagmin-1 Is Released with the Latent Fibroblast Growth Factor-1 Homodimer in Response to Heat Shock* , 1998, The Journal of Biological Chemistry.

[6]  F. Tarantini,et al.  Synaptotagmin-1 Is Required for Fibroblast Growth Factor-1 Release* , 1998, The Journal of Biological Chemistry.

[7]  F. Tarantini,et al.  S100A13 Is Involved in the Regulation of Fibroblast Growth Factor-1 and p40 Synaptotagmin-1 Release in Vitro * , 1998, The Journal of Biological Chemistry.

[8]  V. Gerke,et al.  Hydrophobic residues in the C-terminal region of S100A1 are essential for target protein binding but not for dimerization. , 1998, Cell calcium.

[9]  D. Atar,et al.  Distinct subcellular localization of calcium binding S100 proteins in human smooth muscle cells and their relocation in response to rises in intracellular calcium. , 1998, Journal of cell science.

[10]  T. Maciag,et al.  Activation of the MAP Kinase Pathway by FGF-1 Correlates with Cell Proliferation Induction While Activation of the Src Pathway Correlates with Migration , 1998, The Journal of cell biology.

[11]  M. Sheetz,et al.  Cell migration: regulation of force on extracellular-matrix-integrin complexes. , 1998, Trends in cell biology.

[12]  J. Segall,et al.  EGF stimulates an increase in actin nucleation and filament number at the leading edge of the lamellipod in mammary adenocarcinoma cells. , 1998, Journal of cell science.

[13]  G. Roberts,et al.  Identification of the binding site on S100B protein for the actin capping protein CapZ , 1997, Protein science : a publication of the Protein Society.

[14]  H. Maeta,et al.  Two distinct anti-allergic drugs, amlexanox and cromolyn, bind to the same kinds of calcium binding proteins, except calmodulin, in bovine lung extract. , 1997, Biochemical and biophysical research communications.

[15]  D. Botstein,et al.  Yeast actin cytoskeleton mutants accumulate a new class of Golgi-derived secretary vesicle. , 1997, Molecular biology of the cell.

[16]  Yamei Gao,et al.  Down-regulation of the Filamentous Actin Cross-linking Activity of Cortactin by Src-mediated Tyrosine Phosphorylation* , 1997, The Journal of Biological Chemistry.

[17]  D. Helfman,et al.  Ca2+-dependent interaction of S100A2 with muscle and nonmuscle tropomyosins. , 1997, Journal of cell science.

[18]  J. Winkles,et al.  Postnatal regulation of fibroblast growth factor ligand and receptor gene expression in rat thoracic aorta. , 1996, The American journal of pathology.

[19]  C. Heizmann,et al.  Characterization of the human and mouse cDNAs coding for S100A13, a new member of the S100 protein family. , 1996, Biochemical and biophysical research communications.

[20]  T. Maciag,et al.  FGF-1-dependent proliferative and migratory responses are impaired in senescent human umbilical vein endothelial cells and correlate with the inability to signal tyrosine phosphorylation of fibroblast growth factor receptor-1 substrates , 1996, The Journal of cell biology.

[21]  S. Craig,et al.  Assembly of focal adhesions: progress, paradigms, and portents. , 1996, Current opinion in cell biology.

[22]  R. Friesel,et al.  Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  Richard G. W. Anderson,et al.  Synaptotagmin I is a high affinity receptor for clathrin AP-2: Implications for membrane recycling , 1994, Cell.

[24]  R. Friesel,et al.  Association of fibroblast growth factor receptor-1 with c-Src correlates with association between c-Src and cortactin. , 1994, The Journal of biological chemistry.

[25]  R. Friesel,et al.  Murine cortactin is phosphorylated in response to fibroblast growth factor-1 on tyrosine residues late in the G1 phase of the BALB/c 3T3 cell cycle. , 1993, The Journal of biological chemistry.

[26]  R. Friesel,et al.  Long term growth factor exposure and differential tyrosine phosphorylation are required for DNA synthesis in BALB/c 3T3 cells. , 1993, The Journal of biological chemistry.

[27]  Paul Tempst,et al.  SNAP receptors implicated in vesicle targeting and fusion , 1993, Nature.

[28]  R. Forough,et al.  Heat shock induces the release of fibroblast growth factor 1 from NIH 3T3 cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Nelson Wj Cytoskeleton functions in membrane traffic in polarized epithelial cells. , 1991 .

[30]  K. Burridge,et al.  Alpha-actinin: a direct link between actin and integrins. , 1991, Biochemical Society transactions.

[31]  J. Brugge,et al.  Phosphorylation of c-Src on tyrosine 527 by another protein tyrosine kinase. , 1991, Science.

[32]  T. Südhof,et al.  Domain structure of synaptotagmin (p65) , 1991, The Journal of biological chemistry.

[33]  D. Rifkin,et al.  Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis , 1988, The Journal of cell biology.

[34]  T. Libermann,et al.  An angiogenic growth factor is expressed in human glioma cells. , 1987, The EMBO journal.

[35]  T. Maciag,et al.  An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Hall,et al.  Signaling to the actin cytoskeleton. , 1998, Annual review of cell and developmental biology.

[37]  T. Maciag,et al.  The heparin-binding (fibroblast) growth factor family of proteins. , 1989, Annual review of biochemistry.

[38]  I. Spector,et al.  Latrunculins--novel marine macrolides that disrupt microfilament organization and affect cell growth: I. Comparison with cytochalasin D. , 1989, Cell motility and the cytoskeleton.

[39]  Y. Maki,et al.  Mechanism of action of an antiallergic agent, amlexanox (AA-673), in inhibiting histamine release from mast cells. Acceleration of cAMP generation and inhibition of phosphodiesterase. , 1987, International archives of allergy and applied immunology.